Page last updated: 2024-09-05

sb 216763 and Colitis

sb 216763 has been researched along with Colitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunger, N; Falk, W; Hofmann, C; Obermeier, F; Schölmerich, J1

Other Studies

1 other study(ies) available for sb 216763 and Colitis

ArticleYear
Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:11

    Topics: Adjuvants, Immunologic; Adult; Aged; Animals; CD3 Complex; Cells, Cultured; Chronic Disease; Colitis; Cyclic AMP Response Element-Binding Protein; Cytokines; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Intestines; Lipopolysaccharides; Lithium Chloride; Lymph Nodes; Male; Maleimides; Mice; Mice, Inbred BALB C; Middle Aged; Mucous Membrane; NF-kappa B; Oligodeoxyribonucleotides; Toll-Like Receptors

2010